Vanessa Carle is Secretary of Lexaria Bioscience Corp.. Currently has a direct ownership of 750 shares of LEXX, which is worth approximately $622. The most recent transaction as insider was on Jul 29, 2025, when has been sold 750 shares (Common Shares) at a price of $0.91 per share, resulting in proceeds of $682. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 750
Infinity% 3M change
Infinity% 12M change
Total Value Held $622

Vanessa Carle Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 29 2025
BUY
Open market or private purchase
$682 $0.91 p/Share
750 Added 50.0%
750 Common Shares
Jul 31 2024
SELL
Open market or private sale
$10,268 $4.0 p/Share
2,567 Reduced 100.0%
0 Common Shares
May 14 2024
BUY
Exercise of conversion of derivative security
$2,875 $1.15 p/Share
2,500 Added 49.34%
2,567 Common Shares
VC

Vanessa Carle

Secretary
Kelowna, A1

Track Institutional and Insider Activities on LEXX

Follow Lexaria Bioscience Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LEXX shares.

Notify only if

Insider Trading

Get notified when an Lexaria Bioscience Corp. insider buys or sells LEXX shares.

Notify only if

News

Receive news related to Lexaria Bioscience Corp.

Track Activities on LEXX